|
��չ����
|
|
| ������Ϣ | |
 |
Supporting info |
|
PDFȫ�� |
|
[HTMLȫ��] |
|
����� |
| �����뷴�� | |
|
�������ù����� |
|
���� |
|
Email Alert |
|
���·��� |
|
���������Ϣ |
| ���Ĺؼ���������� | |
|
Ѫ�������յ��� |
|
Ƥ������ |
|
��� |
| ��������������� | |
|
����÷ |
|
������ |
| PubMed | |
|
Article by |
|
Article by |
Ѫ�������Ļ��Ƽ���Ƥ����������м���е�����
����÷, ������
����ҽ�ƴ�ѧ������һҽԺƤ���� 116011
Ѫ����������������м���ķ���������Ҫ����,��Ѫ��������Ϊ��������м�����Ƶ��µİе�Խ��Խ�ܵ����ӡ�Ѫ��������Ѫ�������ٽ����Ӻ��������ӵĵ��ء�����������Ѫ�������Ĺ��̼���صĴٽ����Ӻ��������Ӽ���Ƥ����������м���е����á�
[2] Hanahan D, Folkman J. Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis. Cell, 1996, 86:353-364.
[3] Proniewska-Skretek E, Mariak Z. Tumor angiogensis in uveal melanoma. Role of vascular endothelial growth factor (VEGF). Klin Oczna, 2004, 106:682-685.
[4] Folkman J, D'Amore PA. Blood vessel formation:what is its molec ular basis? Cell, 1996, 87:1153-1155.
[5] Lobov IB, Brooks PC, Lang RA. Angiopoietin-2 displays VEGF-dependent modulation of capillary structure and endothelial cell survival in vivo. Proc Natl Acad Sci U S A, 2002, 99:11205.
[6] Sledge GW Jr, Miller KD. Angiogenesis and antiangiogenic therapy. Curr Probl Cancer, 2002, 26:1-60.
[7] Dixelius J, Cross M, Matsumoto T, et al. Endostatin regulates endothelial cell adhesion and cytoskeletal organization. Cancer Res,2002, 62:1944-1947.
[8] Folkman J. Antiangio genic activity of a matrix protein. Cancer Biol Ther, 2003, 2:53-54.
[9] Streit M, Detmar M. Angiogenesis, lymphangiogenesis, and melanoma metastasis. Oncogene, 2003, 22:3172-3179.
[10] Lin P, Buxton JA, Acheson A, et al. Antiangiogenic gene therapy targeting the endothelium-specific receptor tyrosine kinase Tie2.Proc Natl Acad Sci U S A, 1998, 95:8829-8834.
[11] Detmar M, Velasco P, Richard L, et al. Expression of vascular en dothelial growth factor induces an invasive phenotype in human squamous cell carcinomas. Am J Pathol, 2000, 156:159-167.
[12] Hawighorst T, Velasco P, Streit M, et al. Thrombospondin-2 plays aprotective role in multistep carcinogenesis:a novel host anti-tumor defense mechanism. EMBO J, 2001, 20:2631-2640.
[13] Strieth S, Hartschuh W, Pilz L, et al. Angiogenic switch occurs late in squamous cell carcinomas of human skin. Br J Cancer, 2000, 82:591-600.
[14] Bhushan M, Young HS, Brenchley PE, et al. Recent advances in cutaneous angiogenesis. Br J Dermatol, 2002, 147:418-425.
[15] Brown LF, Dezube BJ, Tognazzi K, et al. Expression of Tie1, Tie2,and angiopoietins 1, 2, and 4 in Kaposi's sarcoma and cutaneous angiosarcoma. Am J Pathol, 2000, 156:2179-2183.
[16] Velasco P, Lange-Asschenfeldt B. Dermatological aspects of angiogenesis. Br J Dermatol, 2002, 147:841-852.
[17] Albini A, Marchisone C, Del Grosso F, et al. Inhibition of angio genesis and vascular tumor growth by interferon-producing cells:A gene therapy approach. Am J Pathol, 2000, 156:1381-1393.
[18] Hem S, Allen MH, Sousa AR, et al. Immunohistochemical evalua tion of psoriatic plaques following selective photothermolysis of the superficial capillaries. Br J Dermatol, 2001, 145:45-53.
[19] Smyth AP, Rook SL, Detmar M, et al. Antisense oligonucleotides inhibit vascular endothelial growth factor/vascular permeability factor expression in normal human epidermal keratinocytes. J Invest Dermatol, 1997, 108:523-526.
[20] �»��,֣��.Ѱ������м������Ѫ����Ƥ�������Ӽ�����ϸ����������-1�����о�.�л�Ƥ������־,2002,35:111-113.